Last reviewed · How we verify

CLIC-2201

British Columbia Cancer Agency · Phase 1 active Biologic

At a glance

Generic nameCLIC-2201
Also known asAutologous CD22 targeting CAR-T cells
SponsorBritish Columbia Cancer Agency
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.